CTRI/2009/091/000676Other未知
Prevalence of atherosclerotic disease in Asian subjects not on lipid-lowering agents, but with at least two CVD risk factors
试验速览
- 阶段
- 未知
- 状态
- Other
- 发起方
- AstraZeneca
- 入组人数
- 3,150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients with at least two CVD risk factors but not on lipid-lowering agents
- •- Provision of signed informed consent.
排除标准
- •- Subjects with CHD, any conditions that may affect hs-CRP levels.
- •- Subjects on any lipid-lowering drug treatment within the last 3 months prior study entry.
研究者
相似试验
进行中（未招募）
不适用
Mediators of Atherosclerosis in South Asians Living in AmericaCardiovascular DiseasesAtherosclerosisHeart DiseasesCoronary DiseaseCoronary Artery DiseaseNCT01207167University of California, San Francisco2,314
已完成
不适用
Study of Artery Conditions of 'At-risk' Asian People Not on Lipid-lowering DrugsCardiovascular DiseaseNCT00970918AstraZeneca2,609
撤回
不适用
Study to Evaluate Subclinical Atherosclerosis (an Early Sign of Heart Disease) in Healthy Adult Immigrant Asian IndiansHealthyNCT01104597Northwell Health
尚未招募
Unknown
A study to assess the cardiovascular disease risk in Indian patientsCTRI/2024/02/062577Sun Pharma Laboratories Ltd.
招募中
不适用
Atherosclerotic Complex coronary Artery Diseases treated by Zotarolimus-Eluting Resolute Onyx stent ~A multi-center registry~JPRN-UMIN000038451Toyohashi Heart Center800